Indazole derivatives as novel bradykinin B1 receptor antagonists

A new class of indazole-derived bradykinin B1 antagonists and their structure–activity relationships (SAR) is reported. A number of compounds were found to have low-nanomolar affinity for the human B1 receptor and possess acceptable P-gp and pharmacokinetics properties.

Figure optionsDownload as PowerPoint slide